Cardlytics, Inc. (NASDAQ:CDLX) Insider Nicholas Hollmeyer Lynton Sells 3,377 Shares

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) insider Nicholas Hollmeyer Lynton sold 3,377 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $3.19, for a total value of $10,772.63. Following the completion of the transaction, the insider now directly owns 94,706 shares in the company, valued at approximately $302,112.14. This trade represents a 3.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Nicholas Hollmeyer Lynton also recently made the following trade(s):

  • On Friday, January 3rd, Nicholas Hollmeyer Lynton sold 6,464 shares of Cardlytics stock. The stock was sold at an average price of $3.67, for a total transaction of $23,722.88.

Cardlytics Stock Performance

CDLX stock traded down $0.10 during midday trading on Thursday, reaching $3.06. 687,561 shares of the company’s stock traded hands, compared to its average volume of 1,027,198. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. Cardlytics, Inc. has a 52 week low of $2.76 and a 52 week high of $20.52. The firm has a market capitalization of $155.51 million, a PE ratio of -0.50 and a beta of 1.53. The company has a 50-day moving average price of $3.64 and a two-hundred day moving average price of $4.26.

Cardlytics (NASDAQ:CDLXGet Free Report) last posted its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.18. The business had revenue of $67.06 million for the quarter, compared to analysts’ expectations of $57.77 million. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The business’s revenue for the quarter was down 15.1% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.26) EPS. As a group, equities analysts anticipate that Cardlytics, Inc. will post -1.52 EPS for the current year.

Institutional Trading of Cardlytics

Institutional investors and hedge funds have recently made changes to their positions in the stock. Atom Investors LP bought a new stake in Cardlytics in the 3rd quarter worth approximately $33,000. Tallon Kerry Patrick purchased a new stake in Cardlytics during the 4th quarter valued at $37,000. SG Americas Securities LLC bought a new stake in shares of Cardlytics in the third quarter worth about $45,000. Intech Investment Management LLC bought a new stake in shares of Cardlytics in the 3rd quarter worth approximately $47,000. Finally, Quadrature Capital Ltd purchased a new position in Cardlytics during the 3rd quarter valued at $63,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Evercore ISI began coverage on shares of Cardlytics in a research report on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target for the company. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Cardlytics has an average rating of “Hold” and a consensus target price of $6.92.

View Our Latest Research Report on Cardlytics

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Read More

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.